Abiopharma

🔍 WONG RICHARD (Executive)

Company: Fastly, Inc. (FSLY)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 16,855 shares of Class A Common Stock at $23.64 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,074,431.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 29,013 shares of Class A Common Stock at $24.29 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,045,418.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,808 shares of Class A Common Stock at $24.95 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,043,610.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.94 to $24.93, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.94 to $24.96, inclusive.